Overview
- The Food and Drug Administration issued marketing granted orders for the JUUL2 device and tobacco‑ and menthol‑flavored pods on Friday, Aug. 28, 2026, allowing Juul to sell those products in the U.S.
- The agency's review concluded a substantial share of adult smokers in Juul’s studies switched completely to the authorized products and that the menthol pod’s added benefit to those adults outweighs identified youth‑appeal risks.
- JUUL2 includes specific youth‑protection technologies: a 21+ age‑gated smartphone app that can lock a paired device, a PodID chip to authenticate pods, and device‑lock functions intended to restrict use to adults.
- Juul said it will seek more FDA filings to expand the JUUL2 line with higher nicotine concentrations and additional flavors aimed at adult nicotine consumers, and the agency stressed the authorization is not an endorsement and non‑smokers should not use e‑cigarettes.
- The authorization raises the total of FDA‑authorized e‑cigarette products to 48 and comes after years of legal and market setbacks for Juul, signaling a possible path for the company to rebuild while regulators and public‑health groups monitor youth vaping trends and market effects.